Source: National Stem Cell Holding, Inc.
Posted: April 11, 2007 1:06 pm ET
Summary:
National Stem Cell Holding, Inc. announced a new study that uses embryonic germ cells to potentially treat type 1 (juvenile) diabetes:
"National Stem Cell has announced the publication of sponsored research whose findings suggest the discovery of a potential source of insulin-producing cells to treat Type I Diabetes. Type I Diabetes, sometimes referred to as Juvenile Diabetes--although it can strike at any age, affects millions of people worldwide. According to the abstract, the scientists were able to, ``show that cells derived from human embryonic germ (EG) cells express markers of definitive endoderm, pancreatic and B-cell development, glucose sensing, and production of mature insulin."
